[{"AccountsPayableCurrent_0_Q3_USD":4017000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":281000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":173000.0,"OtherAssetsNoncurrent_0_Q3_USD":389000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":39000.0,"OperatingIncomeLoss_3_Q3_USD":-51175000.0,"OperatingIncomeLoss_1_Q3_USD":-18533000.0,"OperatingExpenses_3_Q3_USD":54232000.0,"OperatingExpenses_1_Q3_USD":19499000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":9000.0,"NonoperatingIncomeExpense_3_Q3_USD":-100000.0,"NetIncomeLoss_3_Q3_USD":-51275000.0,"NetIncomeLoss_1_Q3_USD":-18651000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-40345000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-65455000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":140881000.0,"MarketableSecuritiesCurrent_0_Q3_USD":150787000.0,"LiabilitiesCurrent_0_Q3_USD":12695000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":217462000.0,"NonoperatingIncomeExpense_1_Q3_USD":-118000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-59000.0,"OtherLiabilitiesCurrent_0_Q3_USD":295000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":148050000.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q3_shares":29491857.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":26663209.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":29491857.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":2291000.0,"StockholdersEquity_0_Q3_USD":201873000.0,"ShareBasedCompensation_3_Q3_USD":7866000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":3057000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":966000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-266117000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":42686000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":15725000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2578000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":10414000.0,"ProfitLoss_3_Q3_USD":-51275000.0,"ProceedsFromStockPlans_3_Q3_USD":1609000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":82956000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3709000.0,"PreferredStockValue_0_Q3_USD":null,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":361000.0,"Liabilities_0_Q3_USD":15589000.0,"WeightedAverageNumberOfSharesIssuedBasic_3_Q3_shares":26663209.0,"InvestmentIncomeAmortizationOfPremium_3_Q3_USD":840000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":-2676000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":59999000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":209155000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":157095000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q3_USD":52060000.0,"AvailableForSaleSecurities_0_Q3_USD":209155000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":209162000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":24000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":17000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":59999000.0,"AssetsCurrent_0_Q3_USD":214495000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":2046367.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":7866000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2291000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":467942000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":45000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":7836000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":670000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":6845000.0,"Assets_0_Q3_USD":217462000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":35081000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":5111841.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":3551000.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_3_Q3_USD":-1.92,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q3_USD":-0.63,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-51275000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-18651000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":11546000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":3774000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-281000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":16100000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.92,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.63,"DepreciationAndAmortization_3_Q3_USD":765000.0,"DepreciationAndAmortization_1_Q3_USD":200000.0,"DeferredRevenueNoncurrent_0_Q3_USD":745000.0,"DeferredRevenueCurrent_0_Q3_USD":1538000.0,"DeferredRentCreditNoncurrent_0_Q3_USD":2149000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-51053000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-18469000.0,"CommonStockValue_0_Q3_USD":3000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-379000.0,"WorkersCompensationLiabilityCurrent_0_Q3_USD":3176000.0,"Ticker":"RAPT","CIK":"1673772","name":"RAPT THERAPEUTICS, INC.","OfficialName":"RAPT Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"595076458.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]